Charles Schwab’s Innovid Corp. CTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-340,931
Closed -$1.05M 3530
2024
Q4
$1.05M Buy
340,931
+53,607
+19% +$127K ﹤0.01% 2896
2024
Q3
$517K Hold
287,324
﹤0.01% 3146
2024
Q2
$532K Buy
287,324
+251,579
+704% +$539K ﹤0.01% 3169
2024
Q1
$89K Hold
35,745
﹤0.01% 3316
2023
Q4
$53.6K Hold
35,745
﹤0.01% 3398
2023
Q3
$45.8K Hold
35,745
﹤0.01% 3415
2023
Q2
$39K Sell
35,745
-174,275
-83% -$181K ﹤0.01% 3454
2023
Q1
$296K Hold
210,020
﹤0.01% 3092
2022
Q4
$359K Buy
210,020
+5,894
+3% +$16K ﹤0.01% 3076
2022
Q3
$554K Buy
204,126
+132,454
+185% +$377K ﹤0.01% 2973
2022
Q2
$119K Buy
71,672
+49,195
+219% +$211K ﹤0.01% 3274
2022
Q1
$136K Buy
+22,477
New +$123K ﹤0.01% 3368

Charles Schwab's CTV Position: Q1 2025 in Review

Charles Schwab sold out of Innovid Corp. (CTV) in Q1 2025, closing a stake of 340,931 shares — an estimated $1.05M sold.

Charles Schwab first reported a position in CTV in Q1 2022 and held it in 12 quarters. The position peaked at $1.05M in Q4 2024. 0 funds tracked by Wall St. Rank hold CTV as of Q1 2025.

  • Charles Schwab reported no remaining Innovid Corp. position as of Q1 2025 after selling out during the quarter.
  • Charles Schwab sold 340,931 Innovid Corp. shares in Q1 2025, an estimated $1.05M.
  • Charles Schwab first reported a position in Innovid Corp. in Q1 2022 and held it in 12 quarters.
  • Charles Schwab's Innovid Corp. position peaked at $1.05M in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Innovid Corp. as of Q1 2025.

Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.